SML1607

Lesinurad

≥98% (HPLC)

• 別名: 2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic acid, RDEA 594
• 実験式（ヒル表記法）: C₁₇H₁₄BrN₃O₂S
• CAS番号: 878672-00-5
• 分子量: 404.28
• MDL番号: MFCD22572730
• UNSPSCコード: 12352200
• PubChem Substance ID: 329825493
• NACRES: NA.77

特性

• 品質水準: 100
• アッセイ: ≥98% (HPLC)
• 形状: powder
• 色: white to beige
• 溶解性: DMSO: 25 mg/mL, clear
• 保管温度: −20°C
• SMILES記法: BrC1=NN=C(SCC(O)=O)N1C2=C3C(C=CC=C3)=C(C4CC4)C=C2
• InChI: 1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)
• InChI Key: FGQFOYHRJSUHMR-UHFFFAOYSA-N
• 遺伝子情報: human ... SLC22A12(116085)

詳細

生物化学的／生理学的作用

Lesinurad is a selective inhibitor of Urate transporter 1 (URAT1), a urate-anion exchanger which is responsible for the majority of uric acid reabsorption from the renal tubular lumen. Lesinurad thus reduces serum uric acid levels. Lesinurad has been approved for use in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable